124 related articles for article (PubMed ID: 21929507)
21. Syntaxin and 25-kDa synaptosomal-associated protein: differential effects of botulinum neurotoxins C1 and A on neuronal survival.
Williamson LC; Neale EA
J Neurosci Res; 1998 Jun; 52(5):569-83. PubMed ID: 9632313
[TBL] [Abstract][Full Text] [Related]
22. A quantitative bifunctional in vitro potency assay for botulinum neurotoxin serotype A.
Gregory RW; Werner WE; Ruegg C
J Pharmacol Toxicol Methods; 2014; 69(2):103-7. PubMed ID: 24333955
[TBL] [Abstract][Full Text] [Related]
23. Neurotransmitter release is blocked intracellularly by botulinum neurotoxin, and this requires uptake of both toxin polypeptides by a process mediated by the larger chain.
Poulain B; Tauc L; Maisey EA; Wadsworth JD; Mohan PM; Dolly JO
Proc Natl Acad Sci U S A; 1988 Jun; 85(11):4090-4. PubMed ID: 2897693
[TBL] [Abstract][Full Text] [Related]
24. [Botulinum neurotoxin].
Poulain B
Rev Neurol (Paris); 2010 Jan; 166(1):7-20. PubMed ID: 19846187
[TBL] [Abstract][Full Text] [Related]
25. Botulinum neurotoxin B inhibits insulin-stimulated glucose uptake into 3T3-L1 adipocytes and cleaves cellubrevin unlike type A toxin which failed to proteolyze the SNAP-23 present.
Chen F; Foran P; Shone CC; Foster KA; Melling J; Dolly JO
Biochemistry; 1997 May; 36(19):5719-28. PubMed ID: 9153412
[TBL] [Abstract][Full Text] [Related]
26. A protein chip membrane-capture assay for botulinum neurotoxin activity.
Marconi S; Ferracci G; Berthomieu M; Kozaki S; Miquelis R; Boucraut J; Seagar M; Lévêque C
Toxicol Appl Pharmacol; 2008 Dec; 233(3):439-46. PubMed ID: 18845174
[TBL] [Abstract][Full Text] [Related]
27. Adeno-associated virus transfer of a gene encoding SNAP-25 resistant to botulinum toxin A attenuates neuromuscular paralysis associated with botulism.
Raghunath A; Perez-Branguli F; Smith L; Dolly JO
J Neurosci; 2008 Apr; 28(14):3683-8. PubMed ID: 18385326
[TBL] [Abstract][Full Text] [Related]
28. Evidence for anterograde transport and transcytosis of botulinum neurotoxin A (BoNT/A).
Restani L; Antonucci F; Gianfranceschi L; Rossi C; Rossetto O; Caleo M
J Neurosci; 2011 Nov; 31(44):15650-9. PubMed ID: 22049408
[TBL] [Abstract][Full Text] [Related]
29. Targeted delivery into motor nerve terminals of inhibitors for SNARE-cleaving proteases via liposomes coupled to an atoxic botulinum neurotoxin.
Edupuganti OP; Ovsepian SV; Wang J; Zurawski TH; Schmidt JJ; Smith L; Lawrence GW; Dolly JO
FEBS J; 2012 Jul; 279(14):2555-67. PubMed ID: 22607388
[TBL] [Abstract][Full Text] [Related]
30. On the action of botulinum neurotoxins A and E at cholinergic terminals.
Washbourne P; Pellizzari R; Rossetto O; Bortoletto N; Tugnoli V; De Grandis D; Eleopra R; Montecucco C
J Physiol Paris; 1998 Apr; 92(2):135-9. PubMed ID: 9782457
[TBL] [Abstract][Full Text] [Related]
31. Neuroscience. A neuronal receptor for botulinum toxin.
Jahn R
Science; 2006 Apr; 312(5773):540-1. PubMed ID: 16645086
[No Abstract] [Full Text] [Related]
32. Synaptic vesicle proteins: targets and routes for botulinum neurotoxins.
Ahnert-Hilger G; Münster-Wandowski A; Höltje M
Curr Top Microbiol Immunol; 2013; 364():159-77. PubMed ID: 23239353
[TBL] [Abstract][Full Text] [Related]
33. Targets for botulinum toxin in the lower urinary tract.
Cruz F
Neurourol Urodyn; 2014 Jan; 33(1):31-8. PubMed ID: 23775898
[TBL] [Abstract][Full Text] [Related]
34. Botulinum A toxin stimulates neurite branching in nerve-muscle cocultures.
Bonner PH; Friedli AF; Baker RS
Brain Res Dev Brain Res; 1994 May; 79(1):39-46. PubMed ID: 8070063
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a vertebrate neuromuscular junction that demonstrates selective resistance to botulinum toxin.
Coffield JA; Bakry NM; Maksymowych AB; Simpson LL
J Pharmacol Exp Ther; 1999 Jun; 289(3):1509-16. PubMed ID: 10336546
[TBL] [Abstract][Full Text] [Related]
36. The effect of botulinum neurotoxin-A on blood flow in rats: a potential mechanism for treatment of Raynaud phenomenon.
Stone AV; Koman LA; Callahan MF; Eckman DM; Smith BP; Plate JF; Smith TL
J Hand Surg Am; 2012 Apr; 37(4):795-802. PubMed ID: 22386546
[TBL] [Abstract][Full Text] [Related]
37. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25.
Blasi J; Chapman ER; Link E; Binz T; Yamasaki S; De Camilli P; Südhof TC; Niemann H; Jahn R
Nature; 1993 Sep; 365(6442):160-3. PubMed ID: 8103915
[TBL] [Abstract][Full Text] [Related]
38. Acute neuroprotection by the synaptic blocker botulinum neurotoxin E in a rat model of focal cerebral ischaemia.
Antonucci F; Cerri C; Maya Vetencourt JF; Caleo M
Neuroscience; 2010 Aug; 169(1):395-401. PubMed ID: 20447449
[TBL] [Abstract][Full Text] [Related]
39. Central effects of tetanus and botulinum neurotoxins.
Caleo M; Schiavo G
Toxicon; 2009 Oct; 54(5):593-9. PubMed ID: 19264088
[TBL] [Abstract][Full Text] [Related]
40. Intrinsic calcium dynamics control botulinum toxin A susceptibility in distinct neuronal populations.
Grumelli C; Corradini I; Matteoli M; Verderio C
Cell Calcium; 2010 May; 47(5):419-24. PubMed ID: 20304487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
